Wouldn't Recommend - Recensione dipendente - Dipendente anonimo presso Transplant Genomics

2,0
25 set 2023
Dipendente anonimo
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

The work being done is amazing, it was nice to know that the results I was putting out had an impact on patient's lives in a very direct way.

Svantaggi

The Lenexa lab was micromanaged in a way that made progress impossible. Upper management churned and burned through two new operations managers in less than 6 months, both had great potential but were completely overwhelmed and hamstrung. Leadership is unaware of the pressures they put on those below them and are contradictory, micromanaging, and uncommunicative. There were constant battles between the sister company of Viracor and the Fremont lab (which no longer exists) You're expected to be perfect.

Esplora altre recensioni su Transplant Genomics

5,0
16 gen 2025
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Well resourced, great and intelligent coworkers, powerful vision and mission

Svantaggi

Some minor politics, but otherwise great

3,0
2 feb 2026
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Great Team, Great Product, Solid Science & product. DEI program is fantastic.

Svantaggi

Eurofins' management of Transplant Genomics and the Diagnostic arm of their testing is very poor. Decisions are made with the bottom line in mind and not of the product or longevity. 2 Major RIFs in 3 years. Paying 20% under going rate across the board.

1
Vedi recensioni per: Utile|Valutazione|Data|Tutto